Patients Included in Biodistribution and Dosimetry Study
| Patient no. | Sex | Pretreatment and predosing | Treatment level (MBq/kg) | Body weight (kg) | Injected activity (MBq) |
| 1 | F | R | 10 | 118 | 1,102 |
| 2 | M | R + L | 10 | 103 | 1,036 |
| 3 | M | R + L | 10 | 73 | 746 |
| 5 | M | R + L | 20 | 97 | 1,982 |
| 13 | M | R | 15 | 94 | 1,416 |
| 14 | F | R | 15 | 71 | 1,013 |
| 15 | M | R | 10 | 113 | 1,137 |
R = pretreated with rituximab; R + L = pretreated with rituximab and predosed with lilotomab.